Next Article in Journal
Biochanin A Ameliorates Arsenic-Induced Hepato- and Hematotoxicity in Rats
Next Article in Special Issue
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Previous Article in Journal
Garlic Supplementation Ameliorates UV-Induced Photoaging in Hairless Mice by Regulating Antioxidative Activity and MMPs Expression
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Design, Synthesis, DFT Study and Antifungal Activity of Pyrazolecarboxamide Derivatives

1
Department of Environmental Engineering, China Jiliang University, Hangzhou 310018, China
2
College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, China
3
Institute of Vegetables and Flowers, Chinese Academy of Agricultural Sciences, Beijing 100014, China
4
College of Biology and Environmental Engineering, Zhejiang Shuren University, Hangzhou 310015, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Submission received: 19 November 2015 / Revised: 30 December 2015 / Accepted: 5 January 2016 / Published: 8 January 2016
(This article belongs to the Special Issue Drug Design and Discovery: Principles and Applications)

Abstract

:
A series of novel pyrazole amide derivatives were designed and synthesized by multi-step reactions from phenylhydrazine and ethyl 3-oxobutanoate as starting materials, and their structures were characterized by NMR, MS and elemental analysis. The antifungal activity of the title compounds was determined. The results indicated that some of title compounds exhibited moderate antifungal activity. Furthermore, DFT calculations were used to study the structure-activity relationships (SAR).

1. Introduction

Heterocyclic structures are important key features in natural products or synthetic medicines and pesticides because of their high-efficiency, low toxicity and diversity of possible substituents [1,2,3,4,5]. This has become a hot research topic in the medicine and pesticides field. Pyrazole is an important kind of heterocyclic nitrogen compound [6,7,8], which derivatives exhibit a wide range of biological activities, such as antifungal [9], insecticidal [10], herbicidal [11], anticancer [12], anti-inflammatory [13] and so on. So far, many pyrazole derivatives such as the insecticides tebufenpyrad and chlorantraniliprole, the fungicides penthiopyrad and pyraclostrobin, and the medicine antipyrine, etc., have been successfully developed by different companies. On the other hand, heterocycles with amide groups are reported as a class of compounds displaying extensive biological activities, such as anti-biofilm [14], herbicidal [15,16], anticancer [17], antifungal [18], antiproliferative [19], plant growth regulation [20] and so on. They represent an important class of natural and synthetic products and extremely versatile building blocks for the manufacture of bioactive compounds in pharmaceutical drug design and the agrochemical industry. In recent years, many succinate-dehydrogenase-inhibitor (SDHI) fungicides had been introduced into the market for effective treatment of fruit and vegetable crops, such as sedaxane, penflufen and benzovindiflupyr (Figure 1). Penflufen is one of the members in this new class of fungicides for the treatment of a wide range of diseases. From Figure 1, the structure of penflufen contains a phenyl ring, an amide group and a 1,3-dimethyl-5-fluoropyrazole moiety.
Figure 1. The commercial pyrazole amide fungicides.
Figure 1. The commercial pyrazole amide fungicides.
Molecules 21 00068 g001
In our previous work, some amide derivatives exhibited excellent herbicidal [21] and fungicidal activity [22]. In line with our continued efforts to synthesize bioactive lead compounds for crop protection [23,24,25,26,27,28,29], the title amide compounds had modified N-substituted pyrazole pharmacophore scaffolds. It is reported that the halogens exhibit similar biological effects. Meanwhile, the aromatic ring also held diverse functions. In order to discover highly active pyrazole amide compounds, the commercial amide fungicide penflufen was selected as a lead compound, and the 1-methyl and 5-fluoro groups on the pyrazole ring were replaced by a phenyl ring and chloro group, respectively. Our original strategy is depicted in Scheme 1. It is possible that pyrazole amide derivatives possess antifungal activities.
Scheme 1. Design strategy of the title compounds.
Scheme 1. Design strategy of the title compounds.
Molecules 21 00068 g004

2. Results and Discussion

2.1. Synthesis and Spectra

In the present paper, a series of pyrazole amide analogues were designed by replacing methyl group and fluorine of penflufen with phenyl and chlorine. First, the pyrazole ring was synthesized from phenylhydrazine and ethyl acetoacetate as starting materials using a classical Knorr reaction, then, using the universal Vilsmeier-Haack reaction, apyrazole with an aldehyde group was obtained in excellent yield. The COOH group can be prepared easily through oxidation with KMnO4. The target compounds were prepared according our previous work [30]. When 5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbonyl chloride was reacted with a substituted amine, organic base Et3N was used instead of the inorganic base K2CO3, while the temperature must be maintained at 0–5 °C, as higher temperatures decreased the yield of product. The imide or lactam product will be obtained.
All the compounds were identified and characterized by 1H-NMR, 13C-NMR, MS and elemental analysis. In the 1H-NMR spectra of target compounds, all the -NH proton signals can be found around 7.59–10.88 ppm. The appearance of a signal around at 2.5 ppm is assigned to the methyl of the pyrazole ring. Meanwhile, most of the title compounds exhibited the M−H peak in the ESI-MS results.

2.2. Antifungal Activities

The in vivo fungicidal results of the title compounds against Pythium ultimum Trow, Phytophthora infestans (Mont.) De Bary, Corynespora cassiicola, Botrytis cinerea and Rhizoctonia solani are listed in Table 1. Zhongshengmycin, dimethomorph, fludioxonil, chlorothalonil and validamycin were used as controls. From Table 1, some of the pyrazole compounds such as compounds 5a (77.78%), 5d (55.56%), 5e (66.67%), 5h (66.67%), 5i (44.44%) and 5l (77.78%) exhibited good control efficacy against Pythium ultimum Trow at a concentration of 100 μg/mL. These compounds show better activity against Pythium ultimum Trow than that of the control. Some of them on the other hand showed low activity (below 40%) against Pythium ultimum Trow, and some of them can’t inhibit Pythium ultimum Trow. For example, compounds 5b (−11.11%), 5f (−55.56%) and 5k (−88.89%) had no inhibitory activity against Pythium ultimum Trow. On the contrary, these compounds increased the fungal growth. The control zhongshengmycin also can’t inhibit the fungus Pythium ultimum Trow. Among the new compounds, compounds 5d (75.33%) and 5h (75.89%) exhibited excellent control efficacy against Corynespora cassiicola, which was better than that of control chlorothalonil (45.9%), while compounds 5a (44.49%), 5c (48.41%) and 5g (46.17%) displayed the same control efficacy as chlorothalonil (45.9%). None of the title compounds exhibited any inhibition effect against Botrytis cinerea and Phytophthora infestans (Mont.) De Bary, except for compound 5h, which displayed weak inhibition (21.38%) of Botrytis cinerea. For the fungus Rhizoctonia solani, most of them had no inhibitory activity, although compound 5a showed a control efficacy of 61.11%, which was similar to that of the most active control fungicide validamycin (62.5%).
Table 1. The antifungal activity of the title compounds in vivo at 100 ppm (%).
Table 1. The antifungal activity of the title compounds in vivo at 100 ppm (%).
No.Pythium ultimumPhytophthora infestansCorynespora cassiicolaBotrytis cinereaRhizoctonia solani
5a77.78−0.8044.49−9.9761.11
5b−11.115.9221.21−17.6935.00
5c11.115.3648.41−10.9431.67
5d55.560.0475.33−52.420.00
5e66.67−0.8023.46−29.270.00
5f−55.56−0.8034.39−11.900.00
5g22.221.4446.17−45.670.00
5h66.67−0.8075.8921.380.00
5i44.446.766.92−13.350.00
5j22.22−0.8032.71−32.160.00
5k−88.89−0.80−0.93−55.310.00
5l77.78−0.80−0.93−36.980.00
Zhongshengmycin0.0
Dimethomorph 97.8
Chlorothalonil 45.9
Fludioxonil 86.98
Validamycin 62.5
Note: Pythium ultimum Trow for tomato, Phytophthora infestans(Mont.) De Bary for tomato, Corynespora cassiicola for cucumber, Botrytis cinerea for cucumber and Rhizoctonia solani for cucumber; All the data were determined three times.

2.3. DFT Calculation and SAR

The total molecular energy and frontier orbital energy levels of compound 5h and penflufen are listed in Table 2. Energy gap between HOMO and LUMO was calculated by B3LYP.
According to the frontier molecular orbital theory, the HOMO and LUMO are the most important factors that affect the bioactivity [31,32]. HOMO has the priority to provide electrons, while the LUMO can accept electrons first. Thus a study of the frontier orbital energy can provide useful information about the biological mechanism of action. We selected the compound 5h with the best antifungal activity among the title compounds and the commercial drug penflufen as models to compare their frontier molecular orbital. Taking the DFT results for example, the geometry of the framework of the compound 5h is hardly influenced by the introduction of either the phenyl ring or the pyrazole ring (Figure 2). The HOMO of the title compound is mainly located on the 3-Me phenyl ring, pyrazole ring and amide bond, while, the LUMO of the title compound is located on the pyrazole ring, 3-Me phenyl ring, phenyl ring, chlorine atom and amide bond. On the other hand, the HOMO of the penflufen is mainly located on the phenyl ring, pyrazole ring, fluorine atom, methyl group and amide bond, while the LUMO of the penflufen is located on the pyrazole ring, phenyl ring and amide bond. From Figure 2, the electron transition ocurrs from the 3-methylbenzene ring, amide bond and pyrazole ring to the N-phenyl ring in compound 5h, while the energy gap between the HOMO and LUMO is 0.16616 Hartree. On the contrary, the electron transition from the phenyl ring, pyrazole ring, fluorine atom, methyl group and amide bond to the phenyl ring, pyrazole ring and amide bond in the compound Penflufen, while the energy gap between the HOMO and LUMO is 0.17984 Hartree. The differences between the two compounds are the electron transition orientation and energy gap. The fact that the title compound has strong affinity suggests the importance of the frontier molecular orbital in the π-π stacking or hydrophobic interactions. This also implies that substituted of phenyl ring had an important impact on the antifungal activity. Furthermore, the MO combination provided meaningful clues as to the structural features of this new family of fungicides that will be helpful in the design of more potent compounds in the future: first the methyl group in the 3-position of pyrazole ring had no impact on the antifungal activity; second for the halo group in the 5-position, a higher group negativity is better; and third, the amide bond is necessary.
Table 2. Total energy and frontier orbital energy.
Table 2. Total energy and frontier orbital energy.
DFT5 hPenflufen
Etotal/Hartree b−1394.96053044−1039.42133553
EHOMO/Hartree−0.21495−0.21213
ELUMO/Hartree−0.04879−0.03229
ΔE a/Hartree0.166160.17984
a ΔE = ELUMOEHOMO; b 1 Hartree = 4.35974417 × 10−18 J = 27.2113845 ev.
Figure 2. Frontier molecular orbitals of compound 5h and penflufen.
Figure 2. Frontier molecular orbitals of compound 5h and penflufen.
Molecules 21 00068 g002
The structural difference is also an important issue. For example, the amide group orientation between the two compounds is opposite (Figure 3). We therefore speculate that this is the confirmation required between the phenyl ring and pyrazole ring when they bind to the target receptor.
Figure 3. Overlay of energy-minimized structures of 5h and penflufen.
Figure 3. Overlay of energy-minimized structures of 5h and penflufen.
Molecules 21 00068 g003

3. Experimental Section

3.1. General Information

All the chemical reagents were analytical grade or prepared in our lab. Melting points were measured using an X-4 apparatus (Taike, Beijing, China) and were uncorrected. 1H-NMR and 13C-NMR spectra were recorded on an Avance 500 MHz spectrometer (Bruker, Fallanden, Switzerland) using CDCl3 as solvent. Mass spectra were determined on a LCQ Advantage LC/mass detector instrument (Thermo Finnigan, Silicon Valley, CA, USA). Elemental analysis data of the title compounds were obtainned by a 240C analyzer (Perkin-Elmer, Waltham, MA, USA).

3.2. Synthesis

3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one (1). Ethyl acetoacetate (13.0 g, 100 mmol) was added to a solution of phenylhydrazine (10.8 g, 100 mmol) in ethanol (20 mL), then the mixture was refluxed for 4 h, then the ethanol was removed under reduced pressure to give compound 1 as a yellow solid (14.3 g, yield 82.6%,m.p.: 125–126 °C).
5-Chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde (2) [33]. Phosphorus oxychloride (250 mmol) was added dropwise into N,N-dimethylformamide (100 mmol) at 0–5 °C. After the mixture was stirred for 30 min, 3-methyl-1-phenyl-1H-pyrazol-5(4H) one (1, 5.22 g, 30 mmol) was added portionwise. Then then mixture was heated to 120 °C for another 1 h. The reaction mixture was poured slowly into crushed ice, and the precipitated solid was filtered and dried, to give 2 as a light yellow solid (5.61 g, yield: 85.0%, m.p.: 136–137 °C).
5-Chloro-3-methyl-1-phenyl-1H-pyrazole-4-carboxylic acid (3) [34]. 5-Chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbaldehyde (2, 5.5 g, 25 mmol) and potassium permanganate (4.74g, 30 mmol) were added to water (50 mL) and refluxed under microwave irradiation for 0.5 h. The reaction mixture was filtered, acidified to pH = 1 using HCl, to give 3 as a white solid that was filtered off and dried (5.6 g, yield: 95%,m.p.: 230–231 °C).
5-Chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbonyl chloride (4) [35]. To 5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-carboxylic acid (3, 7.50 mmol) thionyl chloride (30 mmol) was added and the mixture was refluxed for 2 h. After the reaction is completed, the excess of thionyl chloride were evaporated to give 4 as a yellow liquid that was used without further purification.

General Procedure for the Preparation of Pyrazole Amide Compounds 5am

To a solution of 5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-carbonyl chloride (4, 7 mmol) and Et3N (7.5 mmol) in THF (10 mL), a substituted aniline (7.50 mmol) was added dropwise under 0–5 °C for 1 h. Then the mixture was vigorously stirred at ambient temperature for 8 h, then evaporated under reduced pressure, and subsequently the mixture was exacted with EtOAc. The organic layer was dried over MgSO4 and evaporated. The residue was purified by chromatography on a silica gel column using petroleum ether (60–90 °C) and ethyl acetate as the eluents to afford the title compounds. All the compounds were synthesized according to this procedure (Scheme 2). All the data can be found in Supplementary Materials (see Figures S1–S33 for more details).
Scheme 2. The synthetic route of title compounds. Reagents and Condition: i. EtOH, reflux, 4 h, 83%; ii. POCl3/DMF, 0–5 °C to 120 °C, 1.5 h, 85%; iii. a. KMnO4 H2O, MW, 0.5 h; b. HCl, 95%; iv. SOCl2, reflux, 2 h; v. RNH2, THF, Et3N, r.t., 8 h.
Scheme 2. The synthetic route of title compounds. Reagents and Condition: i. EtOH, reflux, 4 h, 83%; ii. POCl3/DMF, 0–5 °C to 120 °C, 1.5 h, 85%; iii. a. KMnO4 H2O, MW, 0.5 h; b. HCl, 95%; iv. SOCl2, reflux, 2 h; v. RNH2, THF, Et3N, r.t., 8 h.
Molecules 21 00068 g005
5-Chloro-N-(2,4-difluorophenyl)-3-methyl-1-phenyl-1H-pyrazole-4-carboxamide (5a). Yellow solid, m.p. 138–139 °C, yield 94%, 1H-NMR δ: 2.62 (s, 3H, CH3), 6.89–6.94 (m, 2H, Ph-H), 7.49–7.51 (m, 1H, Ph-H), 7.53–7.54 (m, 4H, Ph-H), 8.21 (s, 1H, NH), 8.38–8.44 (m, 1H, Ph-H); 13C-NMR δ: 14.66, 103.57, 111.19, 111.36, 112.79, 122.86, 122.93, 125.54, 126.12, 129.20, 129.27, 137.31, 152.34, 159.78; ESI-MS: 346.04 [M − H], 348.01 [M − H + 2]+, 347.97 [M + H]+, 349.97 [M + H + 2]+; Elemental anal. calculated for C17H12ClF2N3O (%): C, 58.72; H, 3.48; N, 12.08; found: C, 58.90; H, 3.17; N, 12.00.
5-Chloro-3-methyl-N-(4-nitrophenyl)-1-phenyl-1H-pyrazole-4-carboxamide (5b). Yellow solid, m.p. 159–161 °C, yield 98%, 1H-NMR δ: 2.62 (s, 3H, CH3), 7.51–7.55 (m, 5H, Ph-H), 7.83–7.85 (m, 2H, Ph-H), 8.25–8.27 (d, J = 8.0 Hz, 2H, Ph-H), 8.38 (s, 1H, NH); ESI-MS: 355.04 [M − H], 356.97 [M − H + 2]+, 356.97 [M + H]+, 358.98 [M + H + 2]+; Elemental anal. calculated for C17H13ClN4O3 (%): C, 57.23; H, 3.67; N, 15.70; found: C, 57.44; H, 3.57; N, 15.65.
5-Chloro-N-(2,6-dichlorophenyl)-3-methyl-1-phenyl-1H-pyrazole-4-carboxamide (5c). Yellow solid, m.p. 151–153 °C, yield 99%, 1H-NMR δ: 2.61 (s, 3H, CH3), 7.20–7.24 (m, 1H, Ph-H), 7.42–7.43 (d, J = 4.0 Hz, 2H, Ph-H), 7.48–7.55 (m, 5H, Ph-H), 7.76 (s, 1H, NH); ESI-MS: 379.91 [M + H]+, 381.92 [M + H + 2]+; Elemental anal. For C17H12Cl3N3O (%), calculated: C, 53.64; H, 3.18; N, 11.04; found: C, 53.56; H, 3.17; N, 11.32.
5-Chloro-3-methyl-1-phenyl-N-(o-tolyl)-1H-pyrazole-4-carboxamide (5d). Yellow solid, m.p. 132–133 °C, yield 38.4%, 1H-NMR δ: 2.36 (s, 3H, CH3), 2.62 (s, 3H, CH3), 7.09–7.13 (m, 1H, Ph-H), 7.22–7.24 (d, J = 8.0 Hz, 2H, Ph-H), 7.49–7.54 (m, 5H, Ph-H), 7.85 (s, 1H, NH), 8.05–8.07 (m, 1H, Ph-H); 13C-NMR δ: 14.65, 18.13, 113.34, 122.87, 125.08, 125.53, 126.81, 128.61, 129.06, 129.20, 130.50, 135.66, 137.40, 152.40, 159.90; ESI-MS: 324.04 [M − H], 326.11 [M − H + 2]+, 326.01 [M + H]+, 327.99 [M + H + 2]+; Elemental anal. calculated for C18H16ClN3O (%): C, 66.36; H, 4.95; N, 12.90; found: C, 66.43; H, 4.89; N, 13.02.
5-Chloro-3-methyl-N-(4-methyl-2-nitrophenyl)-1-phenyl-1H-pyrazole-4-carboxamide (5e). Yellow solid, m.p. 187–188 °C, yield 71.5%, 1H-NMR δ: 2.42 (s, 3H, CH3), 2.61 (s, 3H, CH3), 7.48–7.50 (m, 1H, Ph-H), 7.51–7.53 (m, 5H, Ph-H), 8.04 (s, 1H, Ph-H), 8.71–8.73 (m, 1H, Ph-H), 10.81 (s, 1H, NH); ESI-MS: 368.98 [M − H] , 370.95 [M − H + 2]+, 371.01 [M + H]+ , 373.00 [M + H + 2]+; Elemental anal. For C18H15ClN4O3 (%), calculated: C, 58.31; H, 4.08; N, 15.11; found: C, 58.23; H, 4.17; N, 14.99.
5-Chloro-N-(4-chloro-2-nitrophenyl)-3-methyl-1-phenyl-1H-pyrazole-4-carboxamide (5f). Yellow solid, m.p. 163–165 °C, yield 96%, 1H-NMR δ: 2.63 (s, 3H, CH3), 6.79–6.81 (m, 1H, Ph-H), 7.51–7.53 (m, 5H, Ph-H), 8.25–8.26 (m, 1H, Ph-H), 8.88–8.91 (m, 1H, Ph-H), 10.88 (s, 1H, NH); ESI-MS: 389.01 [M − H], 390.97 [M − H + 2]+, 392.91 [M − H + 4]+, 391.05 [M + H]+, 393.01 [M − H + 2]+ , 394.99 [M + H + 4]+; Elemental anal. calculated for C17H12Cl2N4O3 (%): C, 52.19; H, 3.09; N, 14.32; found: C, 52.33; H, 3.13; N, 14.15.
5-Chloro-N-(4-fluorophenyl)-3-methyl-1-phenyl-1H-pyrazole-4-carboxamide (5g). Yellow solid, m.p. 154–156 °C, yield 62.2%, 1H-NMR δ: 2.61 (s, 3H, CH3), 7.06–7.10 (m, 2H, Ph-H), 7.50–7.55 (m, 5H, Ph-H), 7.59–7.61 (m, 2H, Ph-H), 7.59 (s, 1H, NH); ESI-MS: 328.06 [M − H], 330.10 [M − H + 2]+, 329.96 [M + H]+, 332.02 [M + H + 2]+; Elemental anal. calculated for C17H13ClFN3O (%): C, 61.92; H, 3.97; N, 12.74; found: C, 61.90; H, 4.17; N, 12.65.
5-Chloro-3-methyl-1-phenyl-N-(m-tolyl)-1H-pyrazole-4-carboxamide (5h). Yellow solid, m.p. 78–81 °C, yield 99%, 1H-NMR δ: 2.37 (s, 3H, CH3), 2.61 (s, 3H, CH3), 6.96–6.98 (m, 1H, Ph-H), 7.23–7.26 (m, 2H, Ph-H), 7.36–7.38 (d, J = 8.0Hz, 1H, Ph-H), 7.51–7.53 (m, 5H, Ph-H), 7.91 (s, 1H, NH); 13C-NMR δ: 14.55, 21.49, 113.36, 117.26, 120.84, 125.41, 125.54, 128.90, 129.08, 129.24, 137.41, 137.53, 139.07, 152.18, 159.91; ESI-MS: 324.08 [M − H], 326.01 [M − H + 2]+, 326.00 [M + H]+, 328.03 [M + H + 2]+; Elemental anal. calculated for C18H16ClN3O (%): C, 66.36; H, 4.95; N, 12.90; found: C, 66.58; H, 4.86; N, 12.13.
5-Chloro-3-methyl-1-phenyl-N-(3-(trifluoromethyl)phenyl)-1H-pyrazole-4-carboxamide (5i). Yellow solid, m.p. 97–98 °C, yield 72.5%, 1H-NMR δ: 2.61 (s, 3H, CH3), 7.39–7.41 (m, 1H, Ph-H), 7.47–7.49 (m, 1H, Ph-H), 7.50–7.54 (m, 5H, Ph-H), 7.80–7.82 (m, 1H, Ph-H), 7.95 (s, 1H, Ph-H), 8.14 (s, 1H, NH); ESI-MS: 378.02 [M − H], 380.00 [M − H + 2]+, 380.02 [M + H]+, 381.93 [M+H+2]+; Elemental anal. calculated for C18H13ClF3N3O (%): C, 58.72; H, 3.48; N, 12.08; found: C, 58.59; H, 3.45; N, 12.12.
5-Chloro-N-(4-chlorophenyl)-3-methyl-1-phenyl-1H-pyrazole-4-carboxamide (5j). Yellow solid, m.p. 161–162 °C, yield 78.1%, 1H-NMR δ: 2.52 (s, 3H, CH3), 7.24–7.26 (m, 2H, Ph-H), 7.43–7.45 (m, 5H, Ph-H), 7.49–7.51 (m, 2H, Ph-H), 7.89 (s, 1H, NH); ESI-MS: 343.92 [M − H], 345.89 [M − H + 2]+, 345.91 [M + H]+, 347.92 [M + H + 2]+; Elemental anal. calculated for C17H13Cl2N3O (%): C, 58.98; H, 3.78; N, 12.14; found: C, 59.11; H, 3.95; N, 12.19.
5-Chloro-N-(4-methoxy-2-nitrophenyl)-3-methyl-1-phenyl-1H-pyrazole-4-carboxamide (5k). Yellow solid, m.p. 157–159 °C, yield 66%, 1H-NMR δ: 2.61 (s, 3H, CH3), 3.88 (s, 3H, CH3), 7.28–7.29 (m, 1H, Ph-H), 7.53–7.55 (m, 5H, Ph-H), 7.70 (s, 1H, Ph-H), 8.71–8.74 (m, 1H, Ph-H), 10.69 (s, 1H, NH) ; ESI-MS: 385.07 [M − H], 387.14 [M − H + 2]+, 386.95 [M + H]+, 389.03 [M+H+2]+; Elemental anal. calculated for C18H15ClN4O4 (%): C, 55.89; H, 3.91; N, 14.49; found: C, 55.98; H, 4.17; N, 14.38.
5-Chloro-3-methyl-1-phenyl-N-(p-tolyl)-1H-pyrazole-4-carboxamide (5l). Yellow solid, m.p. 115–116 °C, yield 73.7%, 1H-NMR δ: 2.34 (s, 3H, CH3), 2.60 (s, 3H, CH3), 7.16–7.18 (m, 2H, Ph-H), 7.47–7.49 (m, 2H, Ph-H), 7.51–7.53 (m, 5H, Ph-H), 7.90 (s, 1H, NH); ESI-MS: 324.03 [M − H], 326.02 [M − H + 2]+, 326.02 [M + H]+, 328.05 [M + H + 2]+; Elemental anal. calculated for C18H16ClN3O (%): C, 66.36; H, 4.95; N, 12.90; found: C, 66.48; H, 5.13; N, 12.88.
5-Chloro-N-(3-chlorophenyl)-3-methyl-1-phenyl-1H-pyrazole-4-carboxamide 5m. Yellow solid, m.p. 81–82 °C, yield 88%, 1H-NMR δ: 2.60 (s, 3H, CH3), 7.11–7.14 (m, 1H, Ph-H), 7.28–7.30 (m, 1H, Ph-H), 7.44–7.46 (m, 1H, Ph-H), 7.52–7.53 (m, 5H, Ph-H), 7.77 (s, 1H, Ph-H), 7.99 (s, 1H, NH); ESI-MS: 343.98 [M − H], 345.98 [M − H + 2]+, 345.96 [M + H]+, 347.93 [M + H + 2]+; Elemental anal. calculated for C17H13Cl2N3O (%): C, 58.98; H, 3.78; N, 12.14; found: C, 59.05; H, 3.87; N, 12.33.

3.3. Antifungal Activity

The antifungal activity of compounds 5a5m against Pythium ultimum Trow, Phytophthora infestans (Mont.) De Bary, Corynespora cassiicola, Botrytis cinerea and Rhizoctonia solani was evaluated according to reference [36,37]. A potted plant test method was adopted. Germination was induced by soaking cucumber seeds in water for 2 h at 50 °C and then keeping the seeds moist for 24 h at 28 °C in an incubator. When the radicles were 0.5 cm, the seeds were grown in plastic pots containing a 1:1 (v/v) mixture of vermiculite and peat. Cucumber plants used for inoculations were at the stage of two cotyledons, and tomato plants were five euphyllas. Tested compounds and commercial fungicides were sprayed with a hand sprayer on the surface of the leaves and on a fine morning, at the standard concentration of 100 μg/mL, each plant was sprayed with compounds and commercial fungicides (200 μL). Dimethomorph, fludioxonil, chlorothalonil, validamycin, and zhongshengmycin were used as controls. After 2 h, inoculations of Phytophthora infestans, Corynespora cassiicola and Botrytis cinerea were carried out by spraying fungal spore suspension with 1 × 104 spore/mL, inoculation of Rhizoctonia solani and Pythium ultimum were carried out by spraying mycelial suspension of 2 × 104 CFU/mL, which was smashed with a T10 basic ULTRA-TURRAX® (IKA, Guangzhou, China). Each kind of inoculum was sprayed at 300 μL/plant. Each treatment was replicated four times. After inoculation, the plants were maintained at 18–30 °C (mean temperature of 24 °C and above 80% relative humidity (RH)). The antifungal activity was evaluated when the non-treated plant (blank) fully developed symptoms. The area of inoculated treated leaves covered by disease symptoms was assessed and compared to that of nontreated ones to determine the average disease index. The relative control efficacy of compounds compared to the blank assay was calculated via the following equation:
relative control efficacy (%) = (CK−PT)/CK × 100%
where CK is the average disease index during the blank assay and PT is the average disease index after treatment during testing. All experiments were replicated three times.

3.4. Theoretical Calculations

According to the above crystal structure, a molecular unit was selected as the initial structure, while the DFT-B3LYP/6-31G (d,p) methods in the Gaussian 03 package [38] were used to optimize the structure of the title compound. Vibration analysis showed that the optimized structures were in accordance with the minimum points on the potential energy surfaces, which means no virtual frequencies, proving that the obtained optimized structures were stable. All the convergent precisions were the system default values, and all the calculations were carried out on the DELL computer.

4. Conclusions

Some interesting pyrazole amide derivatives were designed and synthesized. Their structures were confirmed by NMR, MS and elemental analysis. The antifungal evaluation of the newly synthesized pyrazole amide derivatives showed that among the tested compounds 5-chloro-N-(2,4-difluorophenyl)-3-methyl-1-phenyl-1H-pyrazole-4-carboxamide (5a), 5-chloro-3-methyl-1-phenyl-N-(o-tolyl)-1H-pyrazole-4-carboxamide (5d), 5-chloro-3-methyl-N-(4-methyl-2-nitrophenyl)-1-phenyl-1H-pyrazole-4-carboxamide (5e), 5-chloro-3-methyl-1-phenyl-N-(m-tolyl)-1H-pyrazole-4-carboxamide (5h) and 5-chloro-3-methyl-1-phenyl-N-(p-tolyl)-1H-pyrazole-4-carboxamide (5l) showed good antifungal activity against Pythium ultimum. Interestingly, compound 5d and 5h still exhibited good antifungal activity against Corynespora cassiicola. The best activity compound 5h was selected as a model and its frontier orbitals studied in comparison with the commercial fungicide penflufen.

Supplementary Materials

Supplementary materials can be accessed at: https://0-www-mdpi-com.brum.beds.ac.uk/1420-3049/21/1/68/s1.

Acknowledgments

This work was supported financially by Zhejiang Provincial Science Foundation of China (No. LY16C140007, LQ13B020003) and National Natural Science Foundation of China (No. 31401691, 21205109).

Author Contributions

Jin-Xia Mu, Yan-Xia Shi, Ming-Yan Yang, Zhao-Hui Sun carried out experimental work, Jin-Xia Mu prepared the manuscript, Xing-Hai Liu, Bao-Ju Li designed the material and supervised the project. Na-Bo Sun revised the paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Liu, X.H.; Sun, Z.H.; Yang, M.Y.; Tan, C.X.; Weng, J.Q.; Zhang, Y.G.; Ma, Y. Microwave assistant one pot synthesis, crystal structure, antifungal activities and 3D-QSAR of novel 1,2,4-triazolo[4,3-a]pyridines. Chem. Biol. Drug Des. 2014, 84, 342–347. [Google Scholar] [CrossRef] [PubMed]
  2. Zhai, Z.W.; Yang, M.Y.; Sun, Z.H.; Liu, X.H.; Weng, J.Q.; Tan, C.X. Facile and efficient synthesisof novel 1,2,3-thiadiazole derivatives using microwave irradiation. J. Chem. Res. 2015, 39, 340–342. [Google Scholar]
  3. Zhang, L.J.; Yang, M.Y.; Sun, Z.H.; Tan, C.X.; Weng, J.Q.; Wu, H.K.; Liu, X.H. Synthesis and antifungal activity of 1,3,4-thiadiazole derivatives containing pyridine group. Lett. Drug Des. Discov. 2014, 11, 1107–1111. [Google Scholar] [CrossRef]
  4. Yang, M.Y.; Zhai, Z.W.; Sun, Z.H.; Yu, S.J.; Liu, X.H.; Weng, J.Q.; Tan, C.X.; Zhao, W.G. A facile one-pot synthesis of novel 1,2,4-triazolo[4,3-a]pyridine derivativescontaining the trifluoromethyl moiety using microwave irradiation. J. Chem. Res. 2015, 39, 521–523. [Google Scholar] [CrossRef]
  5. Zhang, L.J.; Yang, M.Y.; Hu, B.Z.; Sun, Z.H.; Liu, X.H.; Weng, J.Q.; Tan, C.X. Microwave-assisted synthesis of novel 8-chloro-[1,2,4]triazolo[4,3-a]pyridinederivatives. Turk. J. Chem. 2015, 39, 867–873. [Google Scholar] [CrossRef]
  6. Lim, J.; Altman, M.D.; Baker, J.; Brubaker, J.D.; Chen, H.M.; Chen, Y.P.; Kleinschek, M.A.; Li, C.M.; Liu, D.; Maclean, J.K.F. Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modifications. Bioorg. Med. Chem. Lett. 2015, 25, 5384–5388. [Google Scholar] [CrossRef] [PubMed]
  7. Liu, X.H.; Tan, C.X.; Weng, J.Q. Synthesis, dimeric crystal, and fungicidal activity of 1- (4-methylphenyl)-2-(5-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)ethanone. Phosphorus Sulfur Silicon Relat. Elem. 2011, 186, 558–564. [Google Scholar] [CrossRef]
  8. Bavetsias, V.; Perez-Fuertes, Y.; McIntyre, P.J.; Atrash, B.; Kosmopoulou, M.; O’Fee, L.; Burke, R.; Sun, C.B.; Faisal, A.; Bush, K. 7-(Pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine-based derivatives for kinase inhibition: Co-crystallisation studies with Aurora-A reveal distinct differences in the orientation of the pyrazole N1-substituent. Bioorg. Med. Chem. Lett. 2015, 25, 4203–4209. [Google Scholar] [CrossRef] [PubMed]
  9. Du, S.; Tian, Z.; Yang, D.; Li, X.; Li, H.; Jia, C.; Che, C.; Wang, M.; Qin, Z. Synthesis, Antifungal Activity and Structure-Activity Relationships of Novel 3-(Difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic Acid Amides. Molecules 2015, 20, 8395–8408. [Google Scholar] [CrossRef] [PubMed]
  10. Fu, C.R.; Pei, J.; Ning, Y.; Liu, M.; Shan, P.C.; Liu, J.; Li, Y.Q.; Hu, F.Z.; Zhu, Y.Q.; Yang, H.Z. Synthesis and insecticidal activities of novel pyrazoleoxime ether derivatives with different substituted pyridyl rings. Pest Manag. Sci. 2014, 70, 1207–1214. [Google Scholar] [CrossRef] [PubMed]
  11. Wu, H.; Feng, J.-T.; Lin, K.-C.; Zhang, X. Synthesis and Herbicidal Activity of Substituted PyrazoleIsothiocyanates. Molecules 2012, 17, 12187–12196. [Google Scholar] [CrossRef] [PubMed]
  12. Ghadbeigi, S.; Ostad, S.N.; Shafiee, A.; Amini, M. Synthesis and Anticancer Activity of 1,3,5-triaryl-1H-pyrazole. Lett. Drug Des. Discov. 2015, 12, 754–759. [Google Scholar] [CrossRef]
  13. Chavan, H.V.; Bandgar, B.P.; Adsul, L.K.; Dhakane, V.D.; Bhale, P.S.; Thakare, V.N.; Masand, V. Design, synthesis, characterization and anti-inflammatory evaluation of novel pyrazole amalgamated flavones. Bioorg. Med. Chem. Lett. 2013, 23, 1315–1321. [Google Scholar] [CrossRef] [PubMed]
  14. Reddy, K.R.; Poornachandra, Y.; Dev, G.J.; Mallareddy, G.; Nanubolu, J.B.; Kumar, C.G.; Narsaiah, B. Synthesis of novel amide functionalized 2H-chromene derivatives by Ritter amidation of primary alcohol using HBF4 center dot OEt2 as a mild and versatile reagent and evaluation of their antimicrobial and anti-biofilm activities. Bioorg. Med. Chem. Lett. 2015, 25, 2943–2947. [Google Scholar] [CrossRef] [PubMed]
  15. Liu, X.H.; Weng, J.Q.; Wang, B.L.; Li, Y.H.; Tan, C.X.; Li, Z.M. Microwave-assisted synthesis of novel fluorinated 1,2,4-triazole derivatives, and study of their biological activity. Res. Chem. Intermed. 2014, 40, 2605–2612. [Google Scholar] [CrossRef]
  16. Weng, J.Q.; Liu, X.H.; Tong, G.T. Synthesis and Herbicidal Activity of Amide Derivatives Containing Thiazole Moiety. Asian J. Chem. 2013, 25, 2149–2152. [Google Scholar]
  17. Antoszczak, M.; Maj, E.; Napiórkowska, A.; Stefańska, J.; Augustynowicz-Kopeć, E.; Wietrzyk, J.; Janczak, J.; Brzezinski, B.; Huczyński, A. Synthesis, Anticancer and Antibacterial Activity of Salinomycin N-Benzyl Amides. Molecules 2014, 19, 19435–19459. [Google Scholar] [CrossRef] [PubMed]
  18. Du, S.; Lu, H.; Yang, D.; Li, H.; Gu, X.; Wan, C.; Jia, C.; Wang, M.; Li, X.; Qin, Z. Synthesis, Antifungal Activity and QSAR of Some Novel Carboxylic Acid Amides. Molecules 2015, 20, 4071–4087. [Google Scholar] [CrossRef] [PubMed]
  19. Wang, Y.H.; Goto, M.; Wang, L.T.; Hsieh, K.Y.; Morris-Natschke, S.L.; Tang, G.H.; Long, C.L.; Lee, K.H. Multidrug resistance-selective antiproliferative activity of Piper amide alkaloids and synthetic analogues. Bioorg. Med. Chem. Lett. 2014, 24, 4818–4821. [Google Scholar] [CrossRef] [PubMed]
  20. Yan, S.L.; Yang, M.Y.; Sun, Z.H.; Min, L.J.; Tan, C.X.; Weng, J.Q.; Wu, H.K.; Liu, X.H. Synthesis and antifungal activity of 1,2,3-thiadiazole derivatives containing 1,3,4-thiadiazole moiety. Lett. Drug Des. Discov. 2014, 11, 940–943. [Google Scholar] [CrossRef]
  21. Liu, X.H.; Chen, P.Q.; Wang, B.L.; Li, Y.H.; Wang, S.H.; Li, Z.M. Synthesis, bioactivity, theoretical and molecular docking study of 1-cyano-N-substituted-cyclopropanecarboxamide as ketol-acid reducto- isomerase inhibitor. Bioorg. Med. Chem. Lett. 2007, 17, 3784–3788. [Google Scholar] [CrossRef] [PubMed]
  22. Liu, X.H.; Shi, Y.X.; Ma, Y.; Zhang, C.Y.; Dong, W.L.; Pan, L.; Wang, B.L.; Li, B.J.; Li, Z.M. Synthesis, antifungal activities and 3D-QSAR study of N-(5-substituted-1,3,4-thiadiazol-2-yl) cyclopropane carboxamides. Eur. J. Med. Chem. 2009, 44, 2182–2786. [Google Scholar] [CrossRef] [PubMed]
  23. Liu, X.H.; Zhai, Z.W.; Xu, X.Y.; Yang, M.Y.; Sun, Z.H.; Weng, J.Q.; Tan, C.X.; Chen, J. Facile and efficient synthesis and herbicidal activity determination of novel 1,2,4-triazolo[4,3-a]pyridin-3(2H)-one derivatives via microwave irradiation. Bioorg. Med. Chem. Lett. 2015, 25, 5524–5528. [Google Scholar] [CrossRef] [PubMed]
  24. Yang, M.Y.; Zhao, W.; Liu, X.H.; Tan, C.X.; Weng, J.Q. Synthesis, crystal structure and antifungal activity of 4-(5-((2,4-dichlorobenzyl)thio)-4-phenyl-4H-1,2,4-triazol-3-yl)pyridine Chin. J. Struct. Chem. 2015, 34, 203–207. [Google Scholar]
  25. Liu, X.H.; Xu, X.Y.; Tan, C.X.; Weng, J.Q.; Xin, J.H.; Chen, J. Synthesis, crystal structure, herbicidal activities and 3D-QSAR study of some novel 1,2,4-triazolo[4,3-a]pyridine derivatives. Pest Manag. Sci. 2015, 71, 292–301. [Google Scholar] [CrossRef] [PubMed]
  26. Sun, Z.H.; Zhai, Z.W.; Yang, M.Y.; Liu, X.H.; Tan, C.X.; Weng, J.Q. Microwave assistant synthesis and dimeric crystal structure of 2-(((6-chloropyridin-3-yl)methyl)thio)-5-(pyridin-4-yl)-1,3,4-thiadiazole. Chin. J. Struct. Chem. 2014, 33, 1779–1783. [Google Scholar]
  27. Zhai, Z.W.; Shi, Y.X.; Yang, M.Y.; Sun, Z.H.; Weng, J.Q.; Tan, C.X.; Liu, X.H.; Li, B.J.; Zhang, Y.G. Synthesis, Crystal Structure, DFT Studies and Antifungal Activity of 5-(4-Cyclopropyl-5-((3-fluorobenzyl)sulfonyl)-4H-1,2,4-triazol-3-yl)-4-methyl-1,2,3-thiadiazole. Chin. J. Struct. Chem. 2016. [Google Scholar]
  28. Shen, Z.H.; Shi, Y.X.; Yang, M.Y.; Sun, Z.H.; Weng, J.Q.; Tan, C.X.; Liu, X.H.; Li, B.J.; Zhao, W.G. Synthesis, Crystal Structure, DFT Studies and Biological Activity of a Novel Schiff Base Containing Triazolo[4,3-a]pyridine Moiety. Chin. J. Struct. Chem. 2016. [Google Scholar] [CrossRef]
  29. Tan, C.X.; Weng, J.Q.; Liu, Z.X.; Liu, X.H.; Zhao, W.G. Synthesis, crystal structure and fungicidal activity of a novel 1,2,3-thiadiazole compound. Phosphorus Sulfur Silicon Relat. Elem. 2012, 187, 990–996. [Google Scholar] [CrossRef]
  30. Liu, X.H.; Pan, L.; Ma, Y.; Weng, J.Q.; Tan, C.X.; Li, Y.H.; Shi, Y.X.; Li, B.J.; Li, Z.M.; Zhang, Y.G. Design, synthesis, biological activities, and 3D-QSAR of new N,N′-diacylhydrazines containing 2-(2,4-dichlorophenoxy)propane moiety. Chem. Biol. Drug Des. 2011, 78, 689–694. [Google Scholar] [CrossRef] [PubMed]
  31. Mu, J.-X.; Zhai, Z.-W.; Yang, M.-Y.; Sun, Z.-H.; Wu, H.-K.; Liu, X.-H. Synthesis, Crystal Structure, DFT Study and Antifungal Activity of 4-(5-((4-Bromobenzyl)thio)-4-Phenyl-4H-1,2,4-Triazol-3-yl)pyridine. Crystals 2016, 6, 4. [Google Scholar] [CrossRef]
  32. Mu, J.-X.; Yang, M.-Y.; Sun, Z.-H.; Tan, C.-X.; Weng, J.-Q.; Wu, H.-K.; Liu, X.-H. Synthesis, Crystal Structure and DFT Studies of 8-chloro-3-((3-chlorobenzyl)thio)-[1,2,4]triazolo[4,3-a]pyridine. Crystals 2015, 5, 491–500. [Google Scholar] [CrossRef]
  33. Rojahn, C.A.; Fahr, K. Synthesis of pyrazole aldehydes. I. Justus Liebigs Ann. Chem. 1923, 434, 252–264. [Google Scholar] [CrossRef]
  34. Zhang, X.L.; Wang, B.L.; Mao, M.Z.; Xiong, L.X.; Yu, S.J.; Li, Z.M. Synthesis and insecticidal activity of 5-Chloro-N-[4-chloro-2-(substituted carbamoyl)-6-methylphenyl]-1-aryl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide. Chin. J. Synthet. Chem. 2009, 17, 342–344. [Google Scholar] [CrossRef]
  35. Lv, X.H.; Zhang, X.L.; Jiang, W.Q. Synthesis of Novel Pyrazole-carboxamide Derivatives Containing Fluorine. Chem. J. Chin. Univ. 2013, 34, 96–102. [Google Scholar]
  36. Zhai, Z.W.; Shi, Y.X.; Yang, M.Y.; Zhao, W.; Sun, Z.H.; Weng, J.Q.; Tan, C.X.; Liu, X.H.; Li, B.J.; Zhang, Y.G. Microwave Assisted Synthesis and Antifungal Activity of Some Novel Thioethers Containing 1,2,4-triazolo[4,3-a]pyridine Moiety. Lett. Drug Des. Discov. 2016. [Google Scholar] [CrossRef]
  37. Wang, L.; Shi, Y.X.; Li, B.J.; Liu, C.L.; Xiang, W.S. Biological Activity of Pyraoxystrobin against Eight Vegetable Pathogens. Chin. J. Pestic. Sci. 2008, 10, 417–422. [Google Scholar]
  38. Frisch, M.-J.; Trucks, G.-W.; Schlegel, H.-B.; Scuseria, G.-E.; Robb, M.-A.; Cheeseman, J.-R.; Montgomery, J.-A., Jr.; Vreven, T.; Kudin, K.-N.; Burant, J.-C.; et al. Gaussian 03, Revision C. 01; Gaussian, Inc.: Wallingford, CT, USA, 2004. [Google Scholar]
  • Sample Availability: Samples of the compounds are available from the authors.

Share and Cite

MDPI and ACS Style

Mu, J.-X.; Shi, Y.-X.; Yang, M.-Y.; Sun, Z.-H.; Liu, X.-H.; Li, B.-J.; Sun, N.-B. Design, Synthesis, DFT Study and Antifungal Activity of Pyrazolecarboxamide Derivatives. Molecules 2016, 21, 68. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules21010068

AMA Style

Mu J-X, Shi Y-X, Yang M-Y, Sun Z-H, Liu X-H, Li B-J, Sun N-B. Design, Synthesis, DFT Study and Antifungal Activity of Pyrazolecarboxamide Derivatives. Molecules. 2016; 21(1):68. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules21010068

Chicago/Turabian Style

Mu, Jin-Xia, Yan-Xia Shi, Ming-Yan Yang, Zhao-Hui Sun, Xing-Hai Liu, Bao-Ju Li, and Na-Bo Sun. 2016. "Design, Synthesis, DFT Study and Antifungal Activity of Pyrazolecarboxamide Derivatives" Molecules 21, no. 1: 68. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules21010068

Article Metrics

Back to TopTop